Biltmore Family Office »

Cadrenal Therapeutics shares owned by Biltmore Family Office

Quarter-by-quarter ownership of Cadrenal Therapeutics (CVKD) shares owned by Biltmore Family Office from 13F filings

Historical chart of Biltmore Family Office investment in Cadrenal Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cadrenal Therapeutics held by Biltmore Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cadrenal Therapeutics by Biltmore Family Office

Quarter filed Position value Share count Share price at filing
2023-09-30 $7.5k 11k 0.68

More positions owned by Biltmore Family Office

Apple (AAPL)
Avidxchange Holdings (AVDX)
Ishares Gold Tr Ishares New (IAU)
Exchange Traded Concepts Tr Robo Glb Etf (ROBO)
Microsoft Corporation (MSFT)
Vanguard Index Fds Large Cap Etf (VV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Real Estate Etf (VNQ)
Aon Shs Cl A (AON)
Merck & Co (MRK)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Vanguard Whitehall Fds High Div Yld (VYM)
Abbvie (ABBV)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Pepsi (PEP)

View all positions for Biltmore Family Office

Top funds holding Cadrenal Therapeutics

Honkamp Krueger Financial Services
Wells Fargo & Company

View all funds holding Cadrenal Therapeutics